Performance/Cognition

BCAAs

Leucine, isoleucine, and valine blend that may slightly reduce workout soreness, but is usually inferior to complete protein.

BCAAs

Leucine, isoleucine, and valine blend that may slightly reduce workout soreness, but is usually inferior to complete protein.

score

evidence

Safe

risk

Proven Benefits

01Improves hepatic encephalopathy

02Reduces exercise soreness

03May lower muscle damage markers

04May preserve lean mass in a cut

05May reduce perceived exercise fatig

Chemical Forms

Recommended

Free-form BCAA powder (2:1:1 leucine:isoleucine:valine)
Capsules or tablets with a disclosed 2:1:1 ratio

Avoid

Proprietary BCAA blends (undisclosed amino acid ratios)
Very high-leucine 'BCAA' formulas (less evidence as a balanced BCAA product)

Expert Note

Most exercise studies use free-form BCAAs in a transparent 2:1:1 leucine:isoleucine:valine ratio. There is no good evidence that fancy delivery systems outperform basic powders or capsules; disclosed dosing matters more. Undisclosed blends make it impossible to know whether the studied balance is present.

Protocol

Amount

5-10 g

Frequency

Once daily on training days, or split before/after exercise

When

30 minutes before or soon after exercise; with a meal if GI upset occurs.

Condition-Based Dosing

Recreational exercise recovery

5-10 g around the workout on training days— Benefits are modest and more likely when training fasted or when total protein intake is low.

Calorie deficit or low-protein meals

5 g with 1-2 protein-poor meals— Do not use BCAAs as a substitute for meeting total daily protein needs.

Cirrhosis or hepatic encephalopathy

Clinician-directed dosing only— Clinical formulas often use specialized, higher-dose regimens that are not appropriate for self-prescribing.

Safety & Limits

Upper Safe Limit

No official UL established; 20 g/day is a practical short-term ceiling used in healthy-adult studies.

Cycling

Safe for continuous use

Contraindications

Maple syrup urine disease — cannot metabolize BCAAs safely

Levodopa — BCAAs can reduce drug effectiveness by competing for transport

Pregnancy or breastfeeding — limited supplemental safety data beyond normal dietary intake

Advanced kidney disease — extra nitrogen load may be inappropriate without clinician guidance

Synergies

Whey protein

BCAAs provide the leucine signal, but complete protein supplies the other essential amino acids needed to sustain muscle protein synthesis.

Avoid Combining With

✕Levodopa (separate by 3+ hours — competes for intestinal and brain transport)
✕Alcohol (can blunt muscle protein synthesis and offset recovery benefits)
✕Protein-rich meals taken with the dose (reduces any unique added value — the meal already provides BCAAs and other EAAs)

Updated Invalid Date